Overview of the genetic basis toward early detection of breast cancer

References

• PonderBAJCancer geneticsNature2001411683533634111357140
   PubMed Web of Science ®Google Scholar
• HanahanDWeinbergRAThe hallmarks of cancerCell20001001577010647931
   PubMed Web of Science ®Google Scholar
• HanahanDWeinbergRAHallmarks of cancer: the next generationCell2011144564667421376230
   PubMed Web of Science ®Google Scholar
• NegriniSGorgoulisVGHalazonetisTDGenomic instability: an evolving hallmark of cancerNat Rev Mol Cell Biol201011322022820177397
   PubMed Web of Science ®Google Scholar
• CoussensLMWerbZInflammation and cancerNature2002420691786086712490959
   PubMed Web of Science ®Google Scholar
• StrattonMRCampbellPJFutrealPAThe cancer genomeNature2009458723971972419360079
   PubMed Web of Science ®Google Scholar
• TalbotSJCrawfordDHViruses and tumours: an updateEur J Cancer200440131998200515315810
   PubMed Web of Science ®Google Scholar
• HaberDASettlemanJCancer: drivers and passengersNature2007446713214514617344839
   PubMed Web of Science ®Google Scholar
• GreenmanCStephensPSmithRPatterns of somatic mutation in human cancer genomesNature2007446713215315817344846
   PubMed Web of Science ®Google Scholar
• International Cancer Genome ConsortiumHudsonTJAndersonWInternational network of cancer genome projectsNature2010464729199399820393554
   PubMed Web of Science ®Google Scholar
• SneddonTPChurchDMOnline resources for genomic structural variationMethods Mol Biol201283827328922228017
   PubMedGoogle Scholar
• ChatterjeeAMamboESidranskyDMitochondrial DNA mutations in human cancerOncogene200625344663467416892080
   PubMed Web of Science ®Google Scholar
• BalmainAGrayJPonderBThe genetics and genomics of cancerNat Genet200333Suppl23824412610533
   PubMed Web of Science ®Google Scholar
• YaoYDaiWGenomic instability and cancerJ Carcinog Mutagen20145100016525541596
   PubMedGoogle Scholar
• HoeijmakersJHJGenome maintenance mechanisms for preventing cancerNature2001411683536637411357144
   PubMed Web of Science ®Google Scholar
• RussoVEAMartienssenRARiggsADEpigenetic Mechanisms of Gene RegulationPlainview, NYCold Spring Harbor Laboratory Press1996
   Google Scholar
• KanwalRGuptaSEpigenetic modifications in cancerClin Genet201281430331122082348
   PubMed Web of Science ®Google Scholar
• SharmaSKellyTKJonesPAEpigenetics in cancerCarcinogenesis2010311273619752007
   PubMed Web of Science ®Google Scholar
• JinBLiYRobertsonKDDNA methylation: superior or subordinate in the epigenetic hierarchy?Genes Cancer20112660761721941617
   PubMedGoogle Scholar
• EstellerMEpigenetics in cancerN Engl J Med2008358111148115918337604
   PubMed Web of Science ®Google Scholar
• PortelaAEstellerMEpigenetic modifications and human diseaseNat Biotechnol201028101057106820944598
   PubMed Web of Science ®Google Scholar
• PfeiferGPBesaratiniaAMutational spectra of human cancerHum Genet20091255–649350619308457
   PubMed Web of Science ®Google Scholar
• JovanovicJRønnebergJATostJKristensenVThe epigenetics of breast cancerMol Oncol20104324225420627830
   PubMed Web of Science ®Google Scholar
• HedenfalkIDugganDChenYGene-expression profiles in hereditary breast cancerN Engl J Med Overseas Ed20013448539548
   PubMed Web of Science ®Google Scholar
• TorreLABrayFSiegelRLFerlayJLortet-TieulentJJemalAGlobal cancer statistics, 2012CA Cancer J Clin20156528710825651787
   PubMed Web of Science ®Google Scholar
• MartinAMWeberBLGenetic and hormonal risk factors in breast cancerJ Natl Cancer Inst200092141126113510904085
   PubMedGoogle Scholar
• BriskenCO’MalleyBHormone action in the mammary glandCold Spring Harb Perspect Biol2010212a00317820739412
   PubMed Web of Science ®Google Scholar
• Collaborative Group on Hormonal Factors in Breast CancerMenarche, menopause, and breast cancer risk: individual participant meta-analysis, including 118 964 women with breast cancer from 117 epidemiological studiesLancet Oncol201213111141115123084519
   PubMed Web of Science ®Google Scholar
• RománMSakshaugSGraff-IversenSPostmenopausal hormone therapy and the risk of breast cancer in NorwayInt J Cancer2016138358459326289549
   PubMed Web of Science ®Google Scholar
• NewcombPATrentham-DietzAHamptonJMLate age at first full term birth is strongly associated with lobular breast cancerCancer201111791946195621509772
   PubMed Web of Science ®Google Scholar
• RonckersCMErdmannCALandCERadiation and breast cancer: a review of current evidenceBreast Cancer Res200571213215642178
   PubMed Web of Science ®Google Scholar
• CoronadoGDBeasleyJLivaudaisJAlcohol consumption and the risk of breast cancerSalud Publica Mex201153544044722218798
   PubMed Web of Science ®Google Scholar
• ClausEBSchildkrautJMThompsonWDRischNJThe genetic attributable risk of breast and ovarian cancerCancer19967711231823248635102
   PubMed Web of Science ®Google Scholar
• MavaddatNAntoniouACEastonDFGarcia-ClosasMGenetic susceptibility to breast cancerMol Oncol20104317419120542480
   PubMed Web of Science ®Google Scholar
• ApostolouPFostiraFHereditary breast cancer: the era of new susceptibility genesBiomed Res Int201320132111
   Web of Science ®Google Scholar
• AntoniouACCasadeiSHeikkinenTBreast-cancer risk in families with mutations in PALB2N Engl J Med2014371649750625099575
   PubMed Web of Science ®Google Scholar
• RippergerTGadzickiDMeindlASchlegelbergerBBreast cancer susceptibility: current knowledge and implications for genetic counsellingEur J Hum Genet200917672273119092773
   PubMed Web of Science ®Google Scholar
• HallMJReidJEBurbidgeLABRCA1 and BRCA2 mutations in women of different ethnicities undergoing testing for hereditary breast-ovarian cancerCancer2009115102222223319241424
   PubMed Web of Science ®Google Scholar
• BalmañaJDíezOCastiglioneMOn behalf of the ESMO Guidelines Working GroupBRCA in breast cancer: ESMO Clinical RecommendationsAnn Oncol200920Suppl 4iv19iv20
   Web of Science ®Google Scholar
• MarmorsteinLYOuchiTAaronsonSAThe BRCA2 gene product functionally interacts with p53 and RAD51Proc Natl Acad Sci USA1998952313869138749811893
   PubMed Web of Science ®Google Scholar
• ChenFMHouMFChangMYHigh frequency of somatic missense mutation of BRCA2 in female breast cancer from TaiwanCancer Lett2005220217718415766593
   PubMed Web of Science ®Google Scholar
• KhooUSOzcelikHCheungANSomatic mutations in the BRCA1 gene in Chinese sporadic breast and ovarian cancerOncogene199918324643464610467410
   PubMed Web of Science ®Google Scholar
• JanatovaMZikanMDundrPMatousBPohlreichPNovel somatic mutations in the BRCA1 gene in sporadic breast tumorsHum Mutat2005253319
   Web of Science ®Google Scholar
• ArmesJEEganAJSoutheyMCThe histologic phenotypes of breast carcinoma occurring before age 40 years in women with and without BRCA1 or BRCA2 germline mutations: a population-based studyCancer19988311233523459840533
   PubMed Web of Science ®Google Scholar
• KingMCMarksJHMandellJBNew York Breast Cancer Study GroupBreast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2Science2003302564564364614576434
   PubMed Web of Science ®Google Scholar
• SatagopanJMOffitKFoulkesWThe lifetime risks of breast cancer in Ashkenazi Jewish carriers of BRCA1 and BRCA2 mutationsCancer Epidemiol Biomarkers Prev200110546747311352856
   PubMed Web of Science ®Google Scholar
• PetoJCollinsNBarfootRPrevalence of BRCA1 and BRCA2 gene mutations in patients with early-onset breast cancerJ Natl Cancer Inst1999911194394910359546
   PubMed Web of Science ®Google Scholar
• ShihHANathansonKLSealSBRCA1 and BRCA2 mutations in breast cancer families with multiple primary cancersClin Cancer Res20006114259426411106241
   PubMed Web of Science ®Google Scholar
• PetrucelliNDalyMBPalTBRCA1- and BRCA2-Associated Hereditary Breast and Ovarian Cancer. 1998 Sep 4 [Updated 2016 Dec 15]AdamMPArdingerHHPagonRAGeneReviews^® [Internet]Seattle (WA)University of Washington Seattle19932018 Available from: https://www.ncbi.nlm.nih.gov/books/NBK1247/Accessed Jun 10, 2018
   Google Scholar
• RoyRChunJPowellSNBRCA1 and BRCA2: different roles in a common pathway of genome protectionNat Rev Cancer2011121687822193408
   PubMed Web of Science ®Google Scholar
• SmithRASaslowDSawyerKAAmerican Cancer Society guidelines for breast cancer screening: update 2003CA Cancer J Clin200353314116912809408
   PubMed Web of Science ®Google Scholar
• ZhangFMaJWuJPALB2 links BRCA1 and BRCA2 in the DNA-damage responseCurr Biol200919652452919268590
   PubMed Web of Science ®Google Scholar
• XiaBDorsmanJCAmezianeNFanconi anemia is associated with a defect in the BRCA2 partner PALB2Nat Genet200739215916117200672
   PubMed Web of Science ®Google Scholar
• SoutheyMCTeoZLDowtyJGA PALB2 mutation associated with high risk of breast cancerBreast Cancer Res2010126R10921182766
   PubMed Web of Science ®Google Scholar
• SoutheyMCWinshipINguyen-DumontTPALB2: research reaching to clinical outcomes for women with breast cancerHered Cancer Clin Pract2016141927099641
   PubMed Web of Science ®Google Scholar
• JanatovaMKleiblZStribrnaJThe PALB2 gene is a strong candidate for clinical testing in BRCA1- and BRCA2-negative hereditary breast cancerCancer Epidemiol Biomarkers Prev201322122323233224136930
   PubMed Web of Science ®Google Scholar
• DingYCSteeleLKuanCJGreilacSNeuhausenSLMutations in BRCA2 and PALB2 in male breast cancer cases from the United StatesBreast Cancer Res Treat2011126377177820927582
   PubMed Web of Science ®Google Scholar
• JonesSHrubanRHKamiyamaMExomic sequencing identifies PALB2 as a pancreatic cancer susceptibility geneScience2009324592421719264984
   PubMed Web of Science ®Google Scholar
• HartleyTCavalloneLSabbaghianNMutation analysis of PALB2 in BRCA1 and BRCA2-negative breast and/or ovarian cancer families from Eastern Ontario, CanadaHered Cancer Clin Pract20141211925225577
   PubMed Web of Science ®Google Scholar
• WalerychDNapoliMCollavinLdel SalGThe rebel angel: mutant p53 as the driving oncogene in breast cancerCarcinogenesis201233112007201722822097
   PubMed Web of Science ®Google Scholar
• VarnaMBousquetGPlassaLFBertheauPJaninATP53 status and response to treatment in breast cancersJ Biomed Biotechnol20112011119
   Google Scholar
• GonzalezKDNoltnerKABuzinCHBeyond Li Fraumeni Syndrome: clinical characteristics of families with p53 germline mutationsJ Clin Oncol20092781250125619204208
   PubMed Web of Science ®Google Scholar
• PetitjeanAAchatzMIBorresen-DaleALHainautPOlivierMTP53 mutations in human cancers: functional selection and impact on cancer prognosis and outcomesOncogene200726152157216517401424
   PubMed Web of Science ®Google Scholar
• de JongMMNolteIMTe MeermanGJGenes other than BRCA1 and BRCA2 involved in breast cancer susceptibilityJ Med Genet200239422524211950848
   PubMed Web of Science ®Google Scholar
• HwangSJLozanoGAmosCIStrongLCGermline p53 mutations in a cohort with childhood sarcoma: sex differences in cancer riskAm J Hum Genet200372497598312610779
   PubMed Web of Science ®Google Scholar
• OliveiraAMRossJSFletcherJATumor suppressor genes in breast cancer: the gatekeepers and the caretakersAm J Clin Pathol2005124SupplS16S2816468415
   PubMedGoogle Scholar
• LiawDMarshDJLiJGermline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndromeNat Genet199716164679140396
   PubMed Web of Science ®Google Scholar
• HobertJAEngCPTEN hamartoma tumor syndrome: an overviewGenet Med2009111068769419668082
   PubMed Web of Science ®Google Scholar
• HearleNSchumacherVMenkoFHFrequency and spectrum of cancers in the Peutz-Jeghers syndromeClin Cancer Res200612103209321516707622
   PubMed Web of Science ®Google Scholar
• MehenniHRestaNParkJGMiyakiMGuantiGCostanzaMCCancer risks in LKB1 germline mutation carriersGut200655798499016407375
   PubMed Web of Science ®Google Scholar
• AhmedMRahmanNATM and breast cancer susceptibilityOncogene200625435906591116998505
   PubMed Web of Science ®Google Scholar
• GoldgarDEHealeySDowtyJGRare variants in the ATM gene and risk of breast cancerBreast Cancer Res2011134R7321787400
   PubMed Web of Science ®Google Scholar
• TaylorAMByrdPJMolecular pathology of ataxia telangiectasiaJ Clin Pathol200558101009101516189143
   PubMed Web of Science ®Google Scholar
• ThompsonDDuedalSKirnerJCancer risks and mortality in heterozygous ATM mutation carriersJ Natl Cancer Inst2005971181382215928302
   PubMedGoogle Scholar
• MilneRLVariants in the ATM gene and breast cancer susceptibilityGenome Med2009111219348699
   PubMed Web of Science ®Google Scholar
• CremonaCABehrensAATM signalling and cancerOncogene201433263351336023851492
   PubMed Web of Science ®Google Scholar
• MangoneFRMiraccaECFeilotterHEMulliganLMNagaiMAATM gene mutations in sporadic breast cancer patients from BrazilSpringerplus201542325625042
   PubMed Web of Science ®Google Scholar
• KeeganTHPressDJTaoLImpact of breast cancer subtypes on 3-year survival among adolescent and young adult womenBreast Cancer Res2013155R9524131591
   PubMed Web of Science ®Google Scholar
• AndersCKJohnsonRLittonJPhillipsMBleyerABreast cancer before age 40 yearsSemin Oncol200936323724919460581
   PubMed Web of Science ®Google Scholar
• Collaborative Group on Hormonal Factors in Breast CancerFamilial breast cancer: collaborative reanalysis of individual data from 52 epidemiological studies including 58,209 women with breast cancer and 101,986 women without the diseaseLancet200135892911389139911705483
   PubMed Web of Science ®Google Scholar
• Al-MoundhriMSAl-AnsariAAl-MawaliKAl-BahraniBBRCA1 gene molecular alterations in Omani breast cancer patientsGulf J Oncol20131144551
   Google Scholar
• BleyerAO’LearyMBarrRRiesLAGCancer Epidemiology in Older Adolescents and Young Adults 15 to 29 Years of Age, Including SEER Incidence and Survival: 1975–2000National Cancer Institute NIH Pub No. 06-5767Bethesda, MD2006
   Google Scholar
• LallooFVarleyJMoranABRCA1, BRCA2 and TP53 mutations in very early-onset breast cancer with associated risks to relativesEur J Cancer20064281143115016644204
   PubMed Web of Science ®Google Scholar
• GruberSBPetersenGMCancer risks in BRCA1 carriers: time for the next generation of studiesJ Natl Cancer Inst200294181344134512237273
   PubMedGoogle Scholar
• AtchleyDPAlbarracinCTLopezAClinical and pathologic characteristics of patients with BRCA-positive and BRCA-negative breast cancerJ Clin Oncol200826264282428818779615
   PubMed Web of Science ®Google Scholar
• KarpSEToninPNBéginLRInfluence of BRCA1 mutations on nuclear grade and estrogen receptor status of breast carcinoma in Ashkenazi Jewish womenCancer19978034354419241077
   PubMed Web of Science ®Google Scholar
• ColleoniMRotmenszNRobertsonCVery young womenAnn Oncol2002132273279
   PubMed Web of Science ®Google Scholar
• AndersCKHsuDSBroadwaterGYoung age at diagnosis correlates with worse prognosis and defines a subset of breast cancers with shared patterns of gene expressionJ Clin Oncol200826203324333018612148
   PubMed Web of Science ®Google Scholar
• FoulkesWDSmithIEReis-FilhoJSTriple-negative breast cancerN Engl J Med2010363201938194821067385
   PubMed Web of Science ®Google Scholar
• LundMJTriversKFPorterPLRace and triple negative threats to breast cancer survival: a population-based study in Atlanta, GABreast Cancer Res Treat2009113235737018324472
   PubMed Web of Science ®Google Scholar
• BadveSDabbsDJSchnittSJBasal-like and triple-negative breast cancers: a critical review with an emphasis on the implications for pathologists and oncologistsMod Pathol201124215716721076464
   PubMed Web of Science ®Google Scholar
• BoylePTriple-negative breast cancer: epidemiological considerations and recommendationsAnn Oncol201223Suppl 6vi7vi1223012306
   PubMed Web of Science ®Google Scholar
• RimawiMFShettyPBWeissHLEpidermal growth factor receptor expression in breast cancer association with biologic phenotype and clinical outcomesCancer201011651234124220082448
   PubMed Web of Science ®Google Scholar
• ChangaviAAShashikalaARamjiASEpidermal growth factor receptor expression in triple negative and nontriple negative breast carcinomasJ Lab Physicians201572798326417156
   PubMedGoogle Scholar
• MavaddatNPeockSFrostDCancer risks for BRCA1 and BRCA2 mutation carriers: results from prospective analysis of EMBRACEJ Natl Cancer Inst20131051181282223628597
   PubMedGoogle Scholar
• WeitzelJNRobsonMPasiniBA comparison of bilateral breast cancers in BRCA carriersCancer Epidemiol Biomarkers Prev20051461534153815941968
   PubMed Web of Science ®Google Scholar
• MusolinoABellaMABortesiBBRCA mutations, molecular markers, and clinical variables in early-onset breast cancer: a population-based studyBreast200716328029217257844
   PubMed Web of Science ®Google Scholar
• SolanoARAcetoGMDelettieresDBRCA1 and BRCA2 analysis of Argentinean breast/ovarian cancer patients selected for age and family history highlights a role for novel mutations of putative south-American originSpringerplus201212023961350
   PubMedGoogle Scholar
• KurianAWBRCA1 and BRCA2 mutations across race and ethnicity: distribution and clinical implicationsCurr Opin Obstet Gynecol2010221727819841585
   PubMed Web of Science ®Google Scholar
• BainesCJMillerABBassettAAPhysical examination. Its role as a single screening modality in the Canadian National Breast Screening StudyCancer1989639181618222702588
   PubMed Web of Science ®Google Scholar
• SchnebleEJGrahamLJShupeMPCurrent approaches and challenges in early detection of breast cancer recurrenceJ Cancer20145428129024790656
   PubMed Web of Science ®Google Scholar
• PedersenACSørensenPDJacobsenEHMadsenJSBrandslundISensitivity of CA 15-3, CEA and serum HER2 in the early detection of recurrence of breast cancerClin Chem Lab Med20135171511151923403727
   PubMed Web of Science ®Google Scholar
• DuffyMJEvoyDMcDermottEWCA 15-3: Uses and limitation as a biomarker for breast cancerClin Chim Acta201041123–241869187420816948
   PubMed Web of Science ®Google Scholar
• DawsonSJTsuiDWMurtazaMAnalysis of circulating tumor DNA to monitor metastatic breast cancerN Engl J Med2013368131199120923484797
   PubMed Web of Science ®Google Scholar
• VolikSAlcaideMMorinRDCollinsCCell-free DNA (cfDNA): clinical significance and utility in cancer shaped by emerging technologiesMol Cancer Res2016141089890827422709
   PubMed Web of Science ®Google Scholar
• ArdekaniAMNaeiniMMThe role of microRNAs in human diseasesAvicenna J Med Biotechnol20102416117923407304
   PubMedGoogle Scholar
• HuYYuCYWangJLGuanJChenHYFangJYMicroRNA sequence polymorphisms and the risk of different types of cancerSci Rep20144364824413317
   PubMed Web of Science ®Google Scholar
• van SchooneveldEWildiersHVergoteIVermeulenPBDirixLYvan LaereSJDysregulation of microRNAs in breast cancer and their potential role as prognostic and predictive biomarkers in patient managementBreast Cancer Res20151712125849621
   PubMed Web of Science ®Google Scholar
• Pérez-RivasLGJerezJMCarmonaRA microRNA signature associated with early recurrence in breast cancerPLoS One201493e9188424632820
   PubMed Web of Science ®Google Scholar
• CostaMSaldanhaPRisk reduction strategies in breast cancer preventionEur J Breast Health201713310311228894848
   PubMed Web of Science ®Google Scholar